Invention Grant
US09592272B2 Treatment of osteoarthritis with incretin hormones or analogues thereof
有权
用肠降血糖素激素或其类似物治疗骨关节炎
- Patent Title: Treatment of osteoarthritis with incretin hormones or analogues thereof
- Patent Title (中): 用肠降血糖素激素或其类似物治疗骨关节炎
-
Application No.: US14424475Application Date: 2013-08-29
-
Publication No.: US09592272B2Publication Date: 2017-03-14
- Inventor: Francis Berenbaum , Carole Bougault , Claire Attali
- Applicant: UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6) , ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS
- Applicant Address: FR Paris FR Paris
- Assignee: UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6),ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS
- Current Assignee: UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6),ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS
- Current Assignee Address: FR Paris FR Paris
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: FR1258100 20120830
- International Application: PCT/FR2013/051998 WO 20130829
- International Announcement: WO2014/023923 WO 20140213
- Main IPC: A61K38/22
- IPC: A61K38/22 ; A61K38/26 ; A61K45/06

Abstract:
The present invention relates to the use of the incretin hormones glucagon-like peptide-1 or GLP-1 and glucose-dependent insulinotropic polypeptide or GIP, or of analogs thereof, in particular the analogs resistant to dipeptidyl peptidase IV, in the treatment of osteoarthritis, in particular for inhibiting or slowing down cartilage destruction.
Public/Granted literature
- US20150209411A1 TREATMENT OF OSTEOARTHRITIS WITH INCRETIN HORMONES OR ANALOGUES THEREOF Public/Granted day:2015-07-30
Information query
IPC分类: